Reports
Global Regenerative Medicine Market: By Technology: Stem Cell Therapy, Biomaterial, Tissue Engineering, Other; By Application: Bone Graft Substitutes, Osteoarticular Diseases, Dermatology, Cardiovascular, Others; Regional Analysis; Historical Market and Forecast (2018-2028); Competitive Landscape; Industry Events and Developments
Global Regenerative Medicine Market Outlook
The global regenerative medicine market attained a value of USD 2.80 million in 2020 and is expected to grow at a CAGR of 11.7% during the forecast period of 2023-2028 owing to increased investment by companies in R&D.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Properties and Applications
Regenerative medicine is a branch of tissue engineering and molecular biology that deals with the method of replacing, regenerating human cells, tissues and organs to restore ordinary function. Regenerative medicine is widely used for bone graft substitutes, osteoarticular diseases, dermatology, cardiovascular, central nervous system, and others.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The regenerative medicine market is segmented based on technology into:
- Stem Cell Therapy
- Biomaterial
- Tissue Engineering
- Other
The EMR report looks further into the regional regenerative medicine markets like the North America, Latin America, Europe, Middle East and Africa, and Asia Pacific.
Market Analysis
The global regenerative medicine market is being driven by high number of clinical trials, growing impact of economy on regenerative medicine, emerging applications of gene therapy in regenerative medicine, increasing funding of government and private sectors to support the development of regenerative medicine, and technological advances in stem cell, tissue engineering, and nanotechnology. The regenerative medicine market is further driven by rising strategic partnership that helps in accelerating commercialisation of regenerative medicine. Rising prevalence of chronic diseases and genetic disorders, degenerative diseases, and bone and joint diseases are other factors leading to rise in demand for regenerative treatments. The high cost of treatment, and regulatory issues pertaining to stem cells, tissues engineering and regenerative medicine, are factors that might hinder the growth of the industry.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Competitive Landscape
The report presents a detailed analysis of the following key players in the regenerative medicine market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Novartis AG
- Vericel Corporation
- Stryker Corporation
- Integra LifeSciences Corporation.
- Mimedx Group Inc.
- Wright Medical Group N.V.
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s five forces.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Technology, Application, Region |
| Breakup by Technology | Stem Cell Therapy, Biomaterial, Tissue Engineering, Other |
| Breakup by Application | Bone Graft Substitutes, Osteoarticular Diseases, Dermatology, Cardiovascular, Central Nervous System, Other Applications |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Novartis AG, Vericel Corporation, Stryker Corporation, Integra Lifesciences Corporation, Mimedx Group Inc., Wright Medical, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Regenerative Medicine Market Analysis
8.1 Key Industry Highlights
8.2 Global Regenerative Medicine Historical Market (2018-2022)
8.3 Global Regenerative Medicine Market Forecast (2023-2028)
8.4 Global Regenerative Medicine Market by Technology
8.4.1 Stem Cell Therapy
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Biomaterials
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.3 Tissue Engineering
8.4.3.2 Historical Trend (2018-2022)
8.4.3.3 Forecast Trend (2023-2028)
8.4.4 Others
8.5 Global Regenerative Medicine Market by Application
8.5.1 Bone Graft Substitutes
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Osteoarticular Diseases
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Dermatology
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.5.4 Cardiovascular
8.5.4.2 Historical Trend (2018-2022)
8.5.4.3 Forecast Trend (2023-2028)
8.5.5 Central Nervous System
8.5.5.2 Historical Trend (2018-2022)
8.5.5.3 Forecast Trend (2023-2028)
8.5.6 Others
8.6 Global Regenerative Medicine Market by Region
8.6.1 North America
8.6.1.1 Historical Trend (2018-2022)
8.6.1.2 Forecast Trend (2023-2028)
8.6.2 Europe
8.6.2.1 Historical Trend (2018-2022)
8.6.2.2 Forecast Trend (2023-2028)
8.6.3 Asia Pacific
8.6.3.1 Historical Trend (2018-2022)
8.6.3.2 Forecast Trend (2023-2028)
8.6.4 Latin America
8.6.4.1 Historical Trend (2018-2022)
8.6.4.2 Forecast Trend (2023-2028)
8.6.5 Middle East and Africa
8.6.5.1 Historical Trend (2018-2022)
8.6.5.2 Forecast Trend (2023-2028)
9 North America Regenerative Medicine Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
10 Europe Regenerative Medicine Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2022)
10.1.2 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Historical Trend (2018-2022)
10.2.2 Forecast Trend (2023-2028)
10.3 France
10.3.1 Historical Trend (2018-2022)
10.3.2 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Historical Trend (2018-2022)
10.4.2 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Regenerative Medicine Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2022)
11.1.2 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Historical Trend (2018-2022)
11.2.2 Forecast Trend (2023-2028)
11.3 India
11.3.1 Historical Trend (2018-2022)
11.3.2 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Historical Trend (2018-2022)
11.4.2 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Historical Trend (2018-2022)
11.5.2 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Regenerative Medicine Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2022)
12.1.2 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Historical Trend (2018-2022)
12.2.2 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Historical Trend (2018-2022)
12.3.2 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Regenerative Medicine Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2022)
13.1.2 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2022)
13.2.2 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Historical Trend (2018-2022)
13.3.2 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Historical Trend (2018-2022)
13.4.2 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Price Analysis
17 Competitive Landscape
17.1 Market Structure
17.2 Company Profiles
17.2.1 Novartis AG
17.2.1.1 Company Overview
17.2.1.2 Product Portfolio
17.2.1.3 Demographic Reach and Achievements
17.2.1.4 Certifications
17.2.2 Vericel Corporation
17.2.2.1 Company Overview
17.2.2.2 Product Portfolio
17.2.2.3 Demographic Reach and Achievements
17.2.2.4 Certifications
17.2.3 Stryker Corporation
17.2.3.1 Company Overview
17.2.3.2 Product Portfolio
17.2.3.3 Demographic Reach and Achievements
17.2.3.4 Certifications
17.2.4 Integra LifeSciences Corporation.
17.2.4.1 Company Overview
17.2.4.2 Product Portfolio
17.2.4.3 Demographic Reach and Achievements
17.2.4.4 Certifications
17.2.5 Mimedx Group Inc.
17.2.5.1 Company Overview
17.2.5.2 Product Portfolio
17.2.5.3 Demographic Reach and Achievements
17.2.5.4 Certifications
17.2.6 Wright Medical Group N.V.
17.2.6.1 Company Overview
17.2.6.2 Product Portfolio
17.2.6.3 Demographic Reach and Achievements
17.2.6.4 Certifications
17.3.7 Others
18 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Regenerative Medicine Market: Key Industry Highlights, 2018 and 2028
2. Global Regenerative Medicine Historical Market: Breakup by Technology (USD Million), 2018-2022
3. Global Regenerative Medicine Market Forecast: Breakup by Technology (USD Million), 2023-2028
4. Global Regenerative Medicine Historical Market: Breakup by Application (USD Million), 2018-2022
5. Global Regenerative Medicine Market Forecast: Breakup by Application (USD Million), 2023-2028
6. Global Regenerative Medicine Historical Market: Breakup by Region (USD Million), 2018-2022
7. Global Regenerative Medicine Market Forecast: Breakup by Region (USD Million), 2023-2028
8. North America Regenerative Medicine Historical Market: Breakup by Country (USD Million), 2018-2022
9. North America Regenerative Medicine Market Forecast: Breakup by Country (USD Million), 2023-2028
10. Europe Regenerative Medicine Historical Market: Breakup by Country (USD Million), 2018-2022
11. Europe Regenerative Medicine Market Forecast: Breakup by Country (USD Million), 2023-2028
12. Asia Pacific Regenerative Medicine Historical Market: Breakup by Country (USD Million), 2018-2022
13. Asia Pacific Regenerative Medicine Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Latin America Regenerative Medicine Historical Market: Breakup by Country (USD Million), 2018-2022
15. Latin America Regenerative Medicine Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Middle East and Africa Regenerative Medicine Historical Market: Breakup by Country (USD Million), 2018-2022
17. Middle East and Africa Regenerative Medicine Market Forecast: Breakup by Country (USD Million), 2023-2028
18. Global Regenerative Medicine Market Structure
Key Questions Answered in the Report
In 2020, the global regenerative medicine market attained a value of nearly USD 2.80 million.
The market is projected to grow at a CAGR of 11.7% between 2023 and 2028.
The major drivers of the industry such as emerging uses of gene therapy, rising prevalence of chronic diseases and genetic disorders, favourable government policies, and increased funding from various organisations are aiding the industry growth.
The key market trends guiding the growth of the industry include technological advancements in the field of stem cell, tissue engineering, and nanotechnology and high number of clinical trials.
The major regional markets are North America, Europe, the Asia Pacific, Latin America and the Middle East and Africa.
Stem cell therapy, biomaterial, and tissue engineering, among others are the major technologies of industry.
Bone graft substitutes, osteoarticular diseases, dermatology, cardiovascular, and central nervous system, among others are the major applications of regenerative medicine.
The major players in the industry are Novartis AG, Vericel Corporation, Stryker Corporation, Integra Lifesciences Corporation, Mimedx Group Inc., Wright Medical, Others.
Analyst Review
The global regenerative medicine market attained a value of USD 2.80 million in 2020 driven by the increasing number of clinical trials. Aided by technological advancements in biotechnology and nanotechnology, and favourable government policies, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 11.7%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on technology, the industry can be segmented into stem cell therapy, biomaterial, and tissue engineering, among others. On the basis of application, the industry can be segmented into bone graft substitutes, osteoarticular diseases, dermatology, cardiovascular, and central nervous system, among others. The major regional markets for the industry are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Novartis AG, Vericel Corporation, Stryker Corporation, Integra Lifesciences Corporation, Mimedx Group Inc., Wright Medical, Others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2799-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER